RenehaVis and SportVis: hyaluronate injections for joint disorders

LSP Bio Ltd has launched two products for the treatment of joint disease: RenehaVis for painful osteoarthritis of the knee and SportVis for ankle sprains and epicondylalgia of the elbow.

RenehaVis: sodium hyaluronate in a dual-chambered prefilled syringe
RenehaVis: sodium hyaluronate in a dual-chambered prefilled syringe

RenehaVis is a sodium hyaluronate product, comprising a dual-chambered prefilled syringe that enables administration of both high and low molecular weight hyaluronate in a single intra-articular injection. Using high and low molecular weight sodium hyaluronate improves both cushioning and elasticity, enabling improvement in movement and pain relief at rest and during activity.

SportVis contains STABHA (Soft Tissue Adapted Biocompatible Hyaluronic Acid) which provides a medium for tissue regeneration that reduces pain and speeds recovery. It is administered by peri-articular injection.

View RenehaVis drug record

View SportVis drug record

Further information: LSP Bio Ltd

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Already registered?
Sign in

MIMS app

Access the full drug database and quick-reference tables on the go

Find out more